PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Cang-Er-Zi-San (CEZS) is evaluated for efficacy and safety compared to conventional therapy [PMID: 39705439]
Sesquiterpene lactones from X. sibiricum alleviate asthma by modulating Th1/Th2 balance in murine models [PMID: 35263672]
Alcohol extracts inhibit proliferation and promote apoptosis of human fibroblast-like synovial-RA cells [PMID: 36596012]; tomentosin shows anti-inflammatory activity in CIA mice [PMID: 37011736]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 19185132 (2009) — Authentication and quantitative analysis on the chemical profile of Xanthium fruit (Cang-Er-Zi) by high-performance liquid chromatography-diode-array detection tandem mass spectrometry method. · Analytica chimica acta
- 2.PMID: 32627466 (2020) — [Chemical constituents from Xanthii Fructus]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
- 3.PMID: 39705439 (2024) — Evaluation of the efficacy and safety of Chinese medicine Cang-Er-Zi-San in the treatment of allergic rhinitis in children: A meta-analysis and systematic review. · Medicine
- 4.PMID: 26357619 (2014) — Traditional Chinese Medicine Induced Liver Injury. · Journal of clinical and translational hepatology
- 5.PMID: 20521353